Evidence map›Paper›PMID 41941363›Full record

ArticleJACC. Case reports2026

Ventricular Tachycardia as the Initial Presentation of Tuberculous Myocarditis.

Arnau Subira-Ingla, Jaume Francisco-Pascual, Alba Santos-Ortega, Maria Nazarena Pizzi, Albert Roque, José F Rodríguez-Palomares, Ignacio Ferreira-González, Gerard Oristrell-Santamaria

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arnau Subira-InglaDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Jaume Francisco-PascualDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain.
Alba Santos-OrtegaDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain; Biomedical Research Networking Centre on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
Maria Nazarena PizziDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain.
Albert RoqueFaculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain; Departments of Radiology and Nuclear Medicine, Vall d'Hebron University Hospital, Barcelona, Spain.
José F Rodríguez-PalomaresDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain; Biomedical Research Networking Centre on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
Ignacio Ferreira-GonzálezDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain; Epidemiology and Public Health Networking Biomedical Research Centre Pública (CIBERESP), Madrid, Spain.
Gerard Oristrell-SantamariaDepartment of Cardiology, Vall d'Hebron University Hospital, Barcelona, Spain; Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Vall d'Hebron Research Institute, Barcelona, Spain; Biomedical Research Networking Centre on Cardiovascular Diseases (CIBERCV), Madrid, Spain. Electronic address: gerard.oristrell@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial involvement in tuberculosis is exceptionally rare and may closely mimic cardiac sarcoidosis, particularly when presenting with ventricular arrhythmias. CASE SUMMARY: A 47-year-old man from a tuberculosis-endemic region presented with sustained monomorphic ventricular tachycardia and biomarker elevation. Coronary angiography was normal. Multimodal imaging demonstrated extensive inflammatory nonischemic myocardial involvement and mediastinal lymphadenopathy. Initial lymph node biopsy showed nonnecrotizing granulomas, leading to a working diagnosis of probable cardiac sarcoidosis and initiation of corticosteroid therapy. Delayed lymph node culture later identified Mycobacterium tuberculosis, prompting revision of the diagnosis and initiation of antituberculous therapy. Despite microbiologic control, recurrent ventricular tachycardia required antiarrhythmic optimization and catheter ablation. DISCUSSION: This case highlights the diagnostic overlap between tuberculous myocarditis and cardiac sarcoidosis and underscores the importance of microbiologic confirmation in patients from endemic regions. TAKE-HOME MESSAGES: Tuberculosis should be considered in granulomatous myocarditis with ventricular arrhythmias. Multimodal imaging combined with extracardiac tissue culture may be decisive in establishing the correct diagnosis.

Indexed as

cardiac magnetic resonancecardiomyopathyelectroanatomical mappingpositron emission tomographyventricular tachycardia

Identifiers

PMID41941363
PMCPMC13184850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.